A global phase III, double-blind, randomized trial of BNT327/PM8002 plus chemotherapy (chemo) compared to atezolizumab plus chemo in patients (pts) with first-line (1L) extensive-stage small cell lung cancer (ES-SCLC).
Year: 2025
Type: article
Source: Journal of Clinical Oncology
Authors: Martin Reck, John Heymach, Kevin Franks, Carl Michael Gay, Vinod Ganju, Ina Nordman, Ying Cheng, Nicolas Girard, Mehmet Ali Nahit Sendur, Ilhan Celik, Isaac Dai, Secil Koseoglu, Sarita Koride, Qiong Wang, Silke Günther, Guoqiang Hu, Özlem Türeci, Ugur Sahin
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410815922